Surfactant proteins: Role in lung physiology and disease in early life

Paediatric Respiratory Reviews

Volumn 2, Issue 2, 2001, Pages 151-158

  Mallory, G B ^a,b  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Hyaline membrane disease; Pulmonary alveolar proteinosis; Pulmonary surfactant; Surfactant protein B deficiency

Indexed keywords

COLLECTIN; HYALIN; LUNG SURFACTANT; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D;

ARTICLE; CONTROLLED STUDY; HOST RESISTANCE; HUMAN; HYALINE MEMBRANE DISEASE; INFANT; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS; LUNG ALVEOLUS PROTEINOSIS; LUNG VOLUME; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SURFACE TENSION;

EID: 0034927312     PISSN: 15260550     EISSN: None     Source Type: Journal    
DOI: 10.1053/prrv.2000.0123     Document Type: Article

References (64)

1. Nerve auffassungen uber einem Grund-befriff der Atemechanik
2. Properties, function and origin of alveolar lining layer
3. Surface tension of lung extracts
4. Surface properties in relation to atelectasis and hyaline membrane disease
5. Composition of surface-active material isolated from beef lung
6. The biochemical development of surface activity in mammalian lung. I. The surface-active phospholipids: The separation and distribution of surface-active lecithin in the lung of the developing rabbit fetus
7. Isolation of apoproteins from canine surface active material
8. Deficiency of surfactant protein B in congenital alveolar proteinosis
9. The pulmonary surfactant system: Biochemical and clinical aspects
10. Immunomodulatory functions of surfactant
11. Regulation of pulmonary surfactant secretion and clearance
12. Regulation of lung surfactant protein secretion
13. Diagnosis of respiratory distress syndrome by amniocentesis
14. The absence of phosphatidylglycerol in surfactant
15. A proposed nomenclature of pulmonary surfactant-associated proteins
16. Purification and biochemical characterization of Cp-4 (SP-D): A collagenous surfactant-associated protein
17. Assignment of the human pulmonary surfactant protein D gene (8FTP4) to 10q22-q23 close to the surfactant protein A gene cluster
18. Surfactant protein A is localized at the corners of the pulmonary tubular myelin lattice
19. Surfactant proteins A and D increase in response to intratracheal lipopolysaccharide
20. Biphasic glucocorticoid regulation of surfactant protein-A: Characterization of the inhibitory process
21. Interferon-gamma and synthesis of surfactant components by cultured human fetal lung
22. Pulmonary surfactant A enhances the host defense mechanism of the rat alveolar macrophages
23. Surfactant protein-A reduces binding and phagocytosis of Pneumocystis carinii by human alveolar macrophages in vitro
24. Inhibition of the human neutrophil respiratory burst by native and synthetic surfactant
25. Rat surfactant apoprotein A (SPA) exhibits antioxidant effects on alveolar macrophages
26. The coding sequence for the human 18,000-Dalton hydrophobic pulmonary surfactant protein is located on chromosome 2 and identifies a restriction fragment length polymorphism
27. Experimental neonatal respiratory failure induced by the monoclonal antibody to the surfactant-associated hydrophobic protein SP-B
28. The gene encoding the hydrophobic surfactant protein SPC is located on the 8p and identifies on EcoRi RFLP
29. Proteolipid in bovine lung surfactant: Its role in surfactant function
30. Pulmonary surfactant protein SP-C causes packing rearrangements of dipalmitoyl phosphotidylcholine in spread monolayers
31. Pulmonary surfactant metabolism in infants lacking surfactant protein B
32. Aberrant processing of surfactant protein C in hereditary SP-B deficiency
33. Genomic organization of human surfactant protein D: SP-D is encoded on chromosome 10q22.2-23.I
34. Regulation of surfactant protein D in human fetal lung
35. Collections and pulmonary host defense
36. Rat surfactant protein D enhances the production of oxygen radicals by rat alveolar macrophages
37. The major glycolipid recognized by SP-D in surfactant is phos-phatidylinositol
38. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome
39. Artificial surfactant therapy in hyaline membrane disease
40. Pulmonary surfactant therapy
41. Birth weight and age specific analysis of the 1990 US infant mortality drop: Was it the surfactant?
42. Surfactant Protein B deficiency: Insights into inherited disorders of lung cell metabolism
43. Molecular and phenotypic vairability in the congenital alveolar proteinosis associated with surfactant protein B deficiency
44. Lung transplantation for treatment of infants with surfactant protein B deficiency
45. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds
46. Surfactant protein B deficiency: Antenatal diagnosis and prospective treatment with surfactant replacement
47. Partial deficiency of surfactant protein B in an infant with chronic lung disease
48. Ultrastructure of lung in surfactant protein B deficiency
49. Congenital alveolar proteinosis caused by a novel mutation of the surfactant protein B gene and misalignment of lung vessels in consanguinous kindred infants
50. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice
51. SP-A deficiency in primate model of BPD with infection in situ mRNA and immunostains
52. Surfactant protein A and D in premature baboons with chronic lung injury (bronchopulmonary dysplasia). Evidence of inhibition of secretion
53. Surfactant protein A. phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid
54. Pulmonary alveolar proteinosis: Clinical aspects and current concepts of pathogenesis
55. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoeisis but develop a characteristic pulmonary pathology
56. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation
57. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice
58. Defective expression of granulocyte-mcarophage colony-stimulating factor/interleukin-3/interleukin- 5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure
59. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect
60. Serologic diagnosis of idiopathic pulmonary alveolar proteinosis
61. A mutation in the surfactant protein C gene associated with familial interstitial lung disease
62. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome
63. Acute effects of a single dose of porcine surfactant on patients with adult respiratory distress syndrome
64. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with CF